Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin vs Campath-1H vs Zenapax in Living Donor Renal Transplantation
NCT01046955Phase 4Completed
- Sponsor
- University of Miami
- Start
- Nov 2005
- Primary completion
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin rabbit, alemtuzumab in kidney transplant rejection, sponsored by University of Miami. Started Nov 2005; status: completed.
02
Drugs
antithymocyte globulin rabbitalemtuzumab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01046955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046955.